President and Chief Executive Officer, TerraPower

Chris Levesque is president and chief executive officer of TerraPower and also serves as a member of the TerraPower Board. He was appointed to that position in November 2018 after having served as president of TerraPower since 2015. Levesque leads this nuclear innovation company in the pursuit of next-generation nuclear energy solutions and also oversees TerraPower’s new venture into therapeutic medical isotopes. His proven track record in scoping, planning and implementing complex projects began with his service in the US Nuclear Navy and features more than thirty years of experience in the nuclear field.

Prior to joining TerraPower, Levesque led major new reactor build efforts at both Westinghouse and AREVA, overseeing projects in both the US and Finland. Before his assignment in Finland, he led the formation of AREVA’s joint venture with Newport News Shipbuilding, AREVA Newport News, for which he served as chairman of the Board and president.

Levesque has extensive experience with the nuclear industrial base and nuclear component manufacturing. Earlier in his career, Levesque served as the manager of engineering and manufacturing at Westinghouse’s Newington, New Hampshire, component manufacturing facility, and he has served in multiple management positions at two nuclear-capable shipyards. Levesque began his career as a nuclear submarine officer and served on both the USS Boise (SSN 764) and the USS Will Rogers (SSBN 659). On Boise, he supervised initial criticality and reactor startup testing, and qualified as chief engineer.

Levesque holds a bachelor of science in mechanical engineering from Rensselaer Polytechnic Institute, a master of science in mechanical engineering and a naval engineer degree from the Massachusetts Institute of Technology. He also serves on the board of the Nuclear Energy Institute.

Subscribe to our newsletter

Sign up to receive our weekly DirectCurrent newsletter to stay up to date on the program’s work.



  • This field is for validation purposes and should be left unchanged.